Exeter academics awarded grants for pioneering fungal research
Two scientists from the The MRC Centre for Medical Mycology, based at the University of Exeter, have received prestigious Springboard Awards from The Academy of Medical Sciences for their research into a deadly fungal disease.
Biomedical researchers Dr Liliane Mukaremera and Dr Carolina Coelho will both use the funding to support their investigations into the fungal pathogen
Cryptococcus neoformans.
Meningitis caused by the pathogen kills many people with weakened immunity, such as those with cancer, organ transplant recipients and HIV/AIDS. In HIV/AIDS patients alone, this meningitis kills over 181,000 people each year even with antifungal treatment.
Dr Carolina Coelho and Dr Liliane Mukaremera
Two scientists from the The MRC Centre for Medical Mycology, based at the University of Exeter, have received prestigious Springboard Awards from The Academy of Medical Sciences for their research into a deadly fungal disease.
Biomedical researchers Dr Liliane Mukaremera and Dr Carolina Coelho will both use the funding to support their investigations into the fungal pathogen Cryptococcus neoformans.
Meningitis caused by the pathogen kills many people with weakened immunity, such as those with cancer, organ transplant recipients and HIV/AIDS. In HIV/AIDS patients alone, this meningitis kills over 181,000 people each year even with antifungal treatment.
Five-year funding boost for fungal research centre
A leading fungal research centre has received a further five years funding from the Medical Research Council (MRC).
The MRC Centre for Medical Mycology, based at the University of Exeter, secured the funding through the renewal of its status as an MRC Centre.
The MRC grant, with significant matched funding from the University of Exeter, will enable the Centre to continue working to address the key challenges of fungal diseases worldwide.
The award includes two new posts that will provide expertise to strengthen work on antifungal drug resistance and the consequences of co-infections.